Intent to Grant an Exclusive License to SciClone Pharmaceuticals

Riepilogo

In compliance with 37 CFR Sec. 404 et seq., the Department of the Army hereby gives notice of its intent to grant to SciClone Pharmaceuticals, a corporation having its principal place of business at 90 Mariner's Island Blvd., San Mateo, CA 94404, an exclusive license under U.S. Patent Applications Serial Numbers 07/878,372 filed 4 May 1992 and 08/145,660 filed 4 November 1993 respectively, and all continuations, continuations-in-part, divisionals, and reissues of the same, and all corresponding foreign patent applications which have been or will be filed. These applications relate to a composition for and a method of treating hepatitis C. Objections along with supporting evidence, if any, should be filed within 60 days from the date of this notice.